| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear body | FAM193B PPIG MYH9 RBM25 ERCC6 DENND1B RALBP1 SMC4 DKC1 SRSF11 RBM8A ZNF470 CDC5L ELL RSRC1 | 2.04e-08 | 903 | 59 | 15 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear speck | FAM193B PPIG RBM25 DENND1B SMC4 SRSF11 RBM8A CDC5L ELL RSRC1 | 3.19e-07 | 431 | 59 | 10 | GO:0016607 |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 2.78e-04 | 9 | 59 | 2 | GO:0071541 | |
| GeneOntologyCellularComponent | septin complex | 6.97e-04 | 14 | 59 | 2 | GO:0031105 | |
| GeneOntologyCellularComponent | septin ring | 6.97e-04 | 14 | 59 | 2 | GO:0005940 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex | 9.16e-04 | 16 | 59 | 2 | GO:0005852 | |
| GeneOntologyCellularComponent | septin cytoskeleton | 9.16e-04 | 16 | 59 | 2 | GO:0032156 | |
| GeneOntologyCellularComponent | eukaryotic 48S preinitiation complex | 1.16e-03 | 18 | 59 | 2 | GO:0033290 | |
| GeneOntologyCellularComponent | eukaryotic 43S preinitiation complex | 1.30e-03 | 19 | 59 | 2 | GO:0016282 | |
| GeneOntologyCellularComponent | translation preinitiation complex | 1.44e-03 | 20 | 59 | 2 | GO:0070993 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MYH9 TAF3 ERCC6 ARID4B BAZ1A NFE2L2 DKC1 RBM8A CDC5L ELL LARP7 | 1.45e-03 | 1377 | 59 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | cell division site | 1.50e-03 | 80 | 59 | 3 | GO:0032153 | |
| MousePheno | enlarged stomach | 5.95e-06 | 33 | 51 | 4 | MP:0003883 | |
| MousePheno | abnormal stomach morphology | ANKRD20A4P BAZ1A NFE2L2 CEP135 ANKRD20A3P ANKRD20A1 ANKRD18B | 3.02e-05 | 248 | 51 | 7 | MP:0000470 |
| Domain | Ank_2 | ASAP2 ANKRD20A4P ANKAR ANKRD11 ANKRD20A2P ANKRD12 ANKRD20A3P ANKRD20A1 | 3.63e-07 | 215 | 59 | 8 | PF12796 |
| Domain | - | ASAP2 ANKRD20A4P ANKAR ANKRD11 ANKRD20A2P ANKRD12 ANKRD20A3P ANKRD20A1 | 1.07e-06 | 248 | 59 | 8 | 1.25.40.20 |
| Domain | ANK | ASAP2 ANKRD20A4P ANKAR ANKRD11 ANKRD20A2P ANKRD12 ANKRD20A3P ANKRD20A1 | 1.17e-06 | 251 | 59 | 8 | SM00248 |
| Domain | ANK_REPEAT | ASAP2 ANKRD20A4P ANKAR ANKRD11 ANKRD20A2P ANKRD12 ANKRD20A3P ANKRD20A1 | 1.24e-06 | 253 | 59 | 8 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ASAP2 ANKRD20A4P ANKAR ANKRD11 ANKRD20A2P ANKRD12 ANKRD20A3P ANKRD20A1 | 1.28e-06 | 254 | 59 | 8 | IPR020683 |
| Domain | ANK_REP_REGION | ASAP2 ANKRD20A4P ANKAR ANKRD11 ANKRD20A2P ANKRD12 ANKRD20A3P ANKRD20A1 | 1.28e-06 | 254 | 59 | 8 | PS50297 |
| Domain | Ankyrin_rpt | ASAP2 ANKRD20A4P ANKAR ANKRD11 ANKRD20A2P ANKRD12 ANKRD20A3P ANKRD20A1 | 1.61e-06 | 262 | 59 | 8 | IPR002110 |
| Domain | Ank | ASAP2 ANKRD20A4P ANKRD11 ANKRD20A2P ANKRD12 ANKRD20A3P ANKRD20A1 | 7.33e-06 | 228 | 59 | 7 | PF00023 |
| Domain | EIF3C_N_dom | 9.81e-06 | 2 | 59 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 9.81e-06 | 2 | 59 | 2 | PF05470 | |
| Domain | EIF3C | 9.81e-06 | 2 | 59 | 2 | IPR027516 | |
| Domain | Septin | 7.48e-04 | 13 | 59 | 2 | PF00735 | |
| Domain | G_SEPTIN_dom | 7.48e-04 | 13 | 59 | 2 | IPR030379 | |
| Domain | G_SEPTIN | 7.48e-04 | 13 | 59 | 2 | PS51719 | |
| Domain | Septin | 8.71e-04 | 14 | 59 | 2 | IPR016491 | |
| Domain | PINT | 1.14e-03 | 16 | 59 | 2 | SM00088 | |
| Domain | PCI_dom | 1.29e-03 | 17 | 59 | 2 | IPR000717 | |
| Domain | PCI | 1.29e-03 | 17 | 59 | 2 | PF01399 | |
| Domain | RRM_1 | 4.22e-03 | 208 | 59 | 4 | PF00076 | |
| Domain | RRM | 4.90e-03 | 217 | 59 | 4 | SM00360 | |
| Domain | RRM_dom | 5.74e-03 | 227 | 59 | 4 | IPR000504 | |
| Domain | RRM | 6.01e-03 | 230 | 59 | 4 | PS50102 | |
| Domain | WHTH_DNA-bd_dom | 7.17e-03 | 242 | 59 | 4 | IPR011991 | |
| Domain | - | 7.37e-03 | 244 | 59 | 4 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 8.94e-03 | 258 | 59 | 4 | IPR012677 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | METAP1 PPIG METTL13 MYH9 RBM25 TAF3 USP42 SMC4 DKC1 SRSF11 RBM8A CDC5L AP3D1 LARP7 RSRC1 RPS27L EIF3CL | 2.07e-10 | 1318 | 65 | 17 | 30463901 |
| Pubmed | MYH9 RBM25 ERCC6 BAZ1A SMC4 DKC1 SRSF11 RBM8A EIF3C CDC5L ELL LARP7 RSRC1 RPS27L | 4.48e-10 | 847 | 65 | 14 | 35850772 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 7.73e-10 | 8 | 65 | 4 | 12634303 | |
| Pubmed | RPF1 PPIG MYH9 RBM25 RRP36 DKC1 SRSF11 RBM8A EIF3C CDC5L RSRC1 RPS27L | 9.89e-09 | 731 | 65 | 12 | 29298432 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | METAP1 RBM25 TAF3 ARID4B BAZ1A ANKRD11 DKC1 CDK11A SRSF11 RBM8A CDC5L ELL RPS27L | 2.02e-08 | 954 | 65 | 13 | 36373674 |
| Pubmed | PPIG METTL13 MYH9 RBM25 TAF3 BAZ1A RALBP1 DKC1 SRSF11 RBM8A EEA1 AP3D1 SEPTIN6 LARP7 RSRC1 | 2.60e-08 | 1371 | 65 | 15 | 36244648 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RPF1 PPIG MYH9 RBM25 TUT4 RRP36 SRSF11 RBM8A EIF3C CDC5L LARP7 RPS27L | 2.93e-08 | 807 | 65 | 12 | 22681889 |
| Pubmed | METAP1 PPIG MYH9 RBM25 BAZ1A DKC1 CDK11A SRSF11 RBM8A EIF3C CDC5L | 3.74e-08 | 660 | 65 | 11 | 32780723 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | JAK1 METAP1 PPIG METTL13 MYH9 ASAP2 RBM25 CEP135 SMC4 SEPTIN11 SRSF11 CDC5L ELL SEPTIN6 | 8.54e-08 | 1284 | 65 | 14 | 17353931 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PPIG MYH9 RBM25 TAF3 MAP1A USP42 DKC1 SRSF11 RBM8A EIF3C CDC5L AP3D1 RPS27L | 8.73e-08 | 1082 | 65 | 13 | 38697112 |
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 9.03e-08 | 59 | 65 | 5 | 16083285 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | METTL13 MYH9 RBM25 RRP36 SMC4 DKC1 CDK11A EIF3C CDC5L AP3D1 RPS27L EIF3CL | 1.69e-07 | 949 | 65 | 12 | 36574265 |
| Pubmed | 3.59e-07 | 653 | 65 | 10 | 33742100 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PPIG MYH9 RBM25 ARID4B USP42 BAZ1A NFE2L2 ANKRD11 DKC1 SRSF11 RBM8A CDC5L RSRC1 | 6.69e-07 | 1294 | 65 | 13 | 30804502 |
| Pubmed | 7.98e-07 | 713 | 65 | 10 | 29802200 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.67e-06 | 774 | 65 | 10 | 15302935 | |
| Pubmed | CYLC1 MYH9 UNCX SBNO1 RRP36 BAZ1A SMC4 DKC1 SRSF11 EEA1 AP3D1 GOLGB1 LARP7 | 2.23e-06 | 1442 | 65 | 13 | 35575683 | |
| Pubmed | PPIG MYH9 RBM25 TAF3 SBNO1 BAZ1A SMC4 DKC1 RBM8A CDC5L LARP7 | 2.60e-06 | 1014 | 65 | 11 | 32416067 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RBM25 RRP36 BAZ1A SMC4 DKC1 SRSF11 RBM8A EIF3C EEA1 CDC5L GOLGB1 | 2.86e-06 | 1024 | 65 | 11 | 24711643 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ASAP2 TUT4 DENND1B RRP36 ANKAR ANKRD11 SEPTIN11 SRSF11 ANKRD12 SYT2 STK32C GOLGB1 SEPTIN6 | 3.17e-06 | 1489 | 65 | 13 | 28611215 |
| Pubmed | METAP1 ERCC6 BAZ1A SMC4 ANKRD11 SEPTIN11 CDK11A RBM8A EIF3C GOLGB1 LARP7 RSRC1 RPS27L | 3.36e-06 | 1497 | 65 | 13 | 31527615 | |
| Pubmed | EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis. | 3.44e-06 | 2 | 65 | 2 | 36157221 | |
| Pubmed | 3.45e-06 | 486 | 65 | 8 | 20936779 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 3.45e-06 | 486 | 65 | 8 | 30940648 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH9 RBM25 SMC4 SEPTIN11 EIF3C EEA1 AP3D1 GOLGB1 SEPTIN6 RPS27L | 3.71e-06 | 847 | 65 | 10 | 35235311 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 5.29e-06 | 235 | 65 | 6 | 30258100 | |
| Pubmed | 7.25e-06 | 538 | 65 | 8 | 28524877 | ||
| Pubmed | 7.80e-06 | 723 | 65 | 9 | 34133714 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 1.02e-05 | 564 | 65 | 8 | 21565611 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 1.14e-05 | 269 | 65 | 6 | 29511261 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | METTL13 MYH9 RBM25 SBNO1 BAZ1A SMC4 DKC1 EIF3C EEA1 CDC5L LARP7 EIF3CL | 1.15e-05 | 1425 | 65 | 12 | 30948266 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.69e-05 | 605 | 65 | 8 | 28977666 | |
| Pubmed | 1.90e-05 | 809 | 65 | 9 | 32129710 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 10504338 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 2.20e-05 | 179 | 65 | 5 | 36261009 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 2.38e-05 | 182 | 65 | 5 | 32239614 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 24113571 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 19145258 | ||
| Pubmed | 3.91e-05 | 202 | 65 | 5 | 29540532 | ||
| Pubmed | 4.28e-05 | 503 | 65 | 7 | 16964243 | ||
| Pubmed | 4.45e-05 | 506 | 65 | 7 | 30890647 | ||
| Pubmed | Aberrant trafficking of the high-affinity choline transporter in AP-3-deficient mice. | 5.13e-05 | 6 | 65 | 2 | 18554297 | |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 19245811 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 5.65e-05 | 358 | 65 | 6 | 32460013 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 5.81e-05 | 934 | 65 | 9 | 33916271 | |
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 30667565 | ||
| Pubmed | Abnormal development of the neuromuscular junction in Nedd4-deficient mice. | 7.18e-05 | 7 | 65 | 2 | 19345204 | |
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 35710093 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 21382013 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 8.36e-05 | 759 | 65 | 8 | 35915203 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 8.99e-05 | 989 | 65 | 9 | 36424410 | |
| Pubmed | Septin 14 is involved in cortical neuronal migration via interaction with Septin 4. | 9.56e-05 | 8 | 65 | 2 | 20181826 | |
| Pubmed | 9.56e-05 | 244 | 65 | 5 | 29884807 | ||
| Pubmed | 1.02e-04 | 399 | 65 | 6 | 35987950 | ||
| Pubmed | 1.22e-04 | 51 | 65 | 3 | 34316707 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 21292980 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 15184363 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 24003236 | ||
| Pubmed | Superfluous role of mammalian septins 3 and 5 in neuronal development and synaptic transmission. | 1.23e-04 | 9 | 65 | 2 | 18809578 | |
| Pubmed | 1.29e-04 | 52 | 65 | 3 | 28893950 | ||
| Pubmed | 1.34e-04 | 419 | 65 | 6 | 15635413 | ||
| Pubmed | CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110). | 1.52e-04 | 55 | 65 | 3 | 23178491 | |
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 16286006 | ||
| Pubmed | Conservation and diversity of eukaryotic translation initiation factor eIF3. | 1.53e-04 | 10 | 65 | 2 | 8995409 | |
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 7851892 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.56e-04 | 271 | 65 | 5 | 32433965 | |
| Pubmed | 1.76e-04 | 441 | 65 | 6 | 31239290 | ||
| Pubmed | 1.87e-04 | 11 | 65 | 2 | 20471949 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.96e-04 | 1353 | 65 | 10 | 29467282 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 2.10e-04 | 289 | 65 | 5 | 23752268 | |
| Pubmed | 2.13e-04 | 156 | 65 | 4 | 22952844 | ||
| Pubmed | 2.22e-04 | 1116 | 65 | 9 | 31753913 | ||
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 14519125 | ||
| Pubmed | Reconstitution reveals the functional core of mammalian eIF3. | 2.24e-04 | 12 | 65 | 2 | 17581632 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 2.41e-04 | 665 | 65 | 7 | 30457570 | |
| Pubmed | 2.46e-04 | 469 | 65 | 6 | 37314180 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 2.52e-04 | 163 | 65 | 4 | 22113938 | |
| Pubmed | 2.65e-04 | 13 | 65 | 2 | 30870432 | ||
| Pubmed | Replication of recently described type 2 diabetes gene variants in a South Indian population. | 2.65e-04 | 13 | 65 | 2 | 20580033 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 2.76e-04 | 1149 | 65 | 9 | 35446349 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 2.81e-04 | 1415 | 65 | 10 | 28515276 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 2.89e-04 | 169 | 65 | 4 | 23084401 | |
| Pubmed | 3.08e-04 | 14 | 65 | 2 | 18599441 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 3.15e-04 | 695 | 65 | 7 | 23602568 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 3.17e-04 | 316 | 65 | 5 | 31665637 | |
| Pubmed | 3.20e-04 | 493 | 65 | 6 | 15368895 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 3.31e-04 | 701 | 65 | 7 | 30196744 | |
| Pubmed | 3.56e-04 | 15 | 65 | 2 | 17322308 | ||
| Pubmed | 3.61e-04 | 325 | 65 | 5 | 36168628 | ||
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 3.67e-04 | 180 | 65 | 4 | 30110629 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 3.81e-04 | 329 | 65 | 5 | 34316702 | |
| Pubmed | 3.97e-04 | 332 | 65 | 5 | 25693804 | ||
| Pubmed | 4.06e-04 | 16 | 65 | 2 | 22792322 | ||
| Pubmed | 4.06e-04 | 16 | 65 | 2 | 22575789 | ||
| Pubmed | 4.37e-04 | 339 | 65 | 5 | 30415952 | ||
| Pubmed | 4.43e-04 | 340 | 65 | 5 | 29478914 | ||
| Pubmed | Proteomic analysis reveals novel ligands and substrates for LNX1 E3 ubiquitin ligase. | 4.45e-04 | 79 | 65 | 3 | 29121065 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.49e-04 | 341 | 65 | 5 | 32971831 | |
| Pubmed | 4.59e-04 | 17 | 65 | 2 | 34752747 | ||
| Pubmed | 4.59e-04 | 17 | 65 | 2 | 1975791 | ||
| Interaction | DDX23 interactions | PPIG RBM25 TAF3 ERCC6 SMC4 ANKRD11 DKC1 CDK11A SRSF11 CDC5L LARP7 RSRC1 | 3.10e-08 | 480 | 64 | 12 | int:DDX23 |
| Interaction | NR2C2 interactions | METAP1 S100B PPIG METTL13 MYH9 RBM25 TAF3 USP42 SMC4 DKC1 SRSF11 RBM8A CDC5L AP3D1 LARP7 RSRC1 RPS27L EIF3CL | 2.19e-07 | 1403 | 64 | 18 | int:NR2C2 |
| Interaction | JMJD6 interactions | 2.72e-07 | 205 | 64 | 8 | int:JMJD6 | |
| Interaction | SRPK1 interactions | PPIG ARID4B SPANXN4 CEP135 SMC4 DKC1 SRSF11 RBM8A CDC5L LARP7 RSRC1 | 2.79e-07 | 477 | 64 | 11 | int:SRPK1 |
| Interaction | ANKRD20A4P interactions | 6.07e-07 | 6 | 64 | 3 | int:ANKRD20A4P | |
| Interaction | IFI6 interactions | 7.73e-07 | 54 | 64 | 5 | int:IFI6 | |
| Interaction | ANKRD20A2P interactions | 1.06e-06 | 7 | 64 | 3 | int:ANKRD20A2P | |
| Interaction | DOT1L interactions | MYH9 RBM25 ERCC6 BAZ1A SMC4 SRSF11 RBM8A EIF3C CDC5L ELL LARP7 RSRC1 RPS27L | 1.23e-06 | 807 | 64 | 13 | int:DOT1L |
| Interaction | SMC5 interactions | METAP1 MYH9 RBM25 TAF3 ARID4B BAZ1A ANKRD11 DKC1 CDK11A SRSF11 RBM8A CDC5L ELL RPS27L | 2.35e-06 | 1000 | 64 | 14 | int:SMC5 |
| Interaction | ZC3H18 interactions | RPF1 PPIG MYH9 RBM25 RRP36 DKC1 CDK11A SRSF11 RBM8A EIF3C CDC5L RSRC1 RPS27L | 3.07e-06 | 877 | 64 | 13 | int:ZC3H18 |
| Interaction | TNIP1 interactions | S100B METTL13 MYH9 RBM25 RRP36 RALBP1 CEP135 SMC4 DKC1 CDK11A EIF3C CDC5L AP3D1 RPS27L EIF3CL | 4.60e-06 | 1217 | 64 | 15 | int:TNIP1 |
| Interaction | ANKRD20A1 interactions | 4.95e-06 | 11 | 64 | 3 | int:ANKRD20A1 | |
| Interaction | EP300 interactions | RPF1 MYH9 RBM25 SBNO1 EGR1 NFE2L2 SMC4 DKC1 SEPTIN11 SRSF11 EIF3C EEA1 CDC5L ELL SEPTIN6 LARP7 | 5.50e-06 | 1401 | 64 | 16 | int:EP300 |
| Interaction | RPS24 interactions | ERCC6 RRP36 ANKRD11 DKC1 CDK11A RBM8A EIF3C LARP7 RPS27L EIF3CL | 6.05e-06 | 529 | 64 | 10 | int:RPS24 |
| Interaction | HDAC1 interactions | MYH9 RBM25 ERCC6 ARID4B BAZ1A NFE2L2 RALBP1 CEP135 SMC4 EIF3C ELL GOLGB1 LARP7 RPS27L | 7.68e-06 | 1108 | 64 | 14 | int:HDAC1 |
| Interaction | CSNK2A1 interactions | MYH9 ARID4B EGR1 BAZ1A ANKRD11 DKC1 CDK11A SRSF11 EIF3C CDC5L LARP7 RSRC1 EIF3CL | 7.85e-06 | 956 | 64 | 13 | int:CSNK2A1 |
| Interaction | MECP2 interactions | RPF1 PPIG MYH9 RBM25 TAF3 MAP1A USP42 BAZ1A DKC1 SRSF11 RBM8A EIF3C CDC5L AP3D1 RPS27L | 9.05e-06 | 1287 | 64 | 15 | int:MECP2 |
| Interaction | NUPR1 interactions | METAP1 PPIG MYH9 RBM25 BAZ1A DKC1 CDK11A SRSF11 RBM8A EIF3C CDC5L | 9.06e-06 | 683 | 64 | 11 | int:NUPR1 |
| Interaction | ZCCHC10 interactions | 9.73e-06 | 236 | 64 | 7 | int:ZCCHC10 | |
| Interaction | PARP1 interactions | ASAP2 RBM25 TAF3 ERCC6 ARID4B BAZ1A SMC4 DKC1 CDK11A RBM8A EIF3C EEA1 CDC5L AP3D1 LARP7 | 1.18e-05 | 1316 | 64 | 15 | int:PARP1 |
| Interaction | EIF3L interactions | 1.21e-05 | 244 | 64 | 7 | int:EIF3L | |
| Interaction | EIF3A interactions | 1.61e-05 | 355 | 64 | 8 | int:EIF3A | |
| Interaction | EIF3C interactions | 1.96e-05 | 263 | 64 | 7 | int:EIF3C | |
| Interaction | CDK11B interactions | 2.50e-05 | 183 | 64 | 6 | int:CDK11B | |
| Interaction | RBBP7 interactions | 3.03e-05 | 507 | 64 | 9 | int:RBBP7 | |
| Interaction | ACAP3 interactions | 3.90e-05 | 21 | 64 | 3 | int:ACAP3 | |
| Interaction | RPL31 interactions | 5.23e-05 | 680 | 64 | 10 | int:RPL31 | |
| Interaction | USP15 interactions | 5.38e-05 | 546 | 64 | 9 | int:USP15 | |
| Interaction | TOP1 interactions | JAK1 RBM25 ERCC6 ARID4B BAZ1A RALBP1 SRSF11 RBM8A CDC5L LARP7 | 6.35e-05 | 696 | 64 | 10 | int:TOP1 |
| Interaction | RBM25 interactions | 7.23e-05 | 323 | 64 | 7 | int:RBM25 | |
| Interaction | SRSF1 interactions | 7.49e-05 | 570 | 64 | 9 | int:SRSF1 | |
| Interaction | MEN1 interactions | JAK1 MYH9 RBM25 ERCC6 SBNO1 BAZ1A SMC4 DKC1 RBM8A EIF3C AP3D1 RPS27L | 8.25e-05 | 1029 | 64 | 12 | int:MEN1 |
| Interaction | H2BC5 interactions | 8.42e-05 | 331 | 64 | 7 | int:H2BC5 | |
| Interaction | SEPTIN7 interactions | 8.51e-05 | 228 | 64 | 6 | int:SEPTIN7 | |
| Interaction | RPS6 interactions | RPF1 AFAP1L2 ERCC6 DKC1 RBM8A CDC5L GOLGB1 ANKRD18B LARP7 RPS27L EIF3CL | 8.68e-05 | 874 | 64 | 11 | int:RPS6 |
| Interaction | SRP72 interactions | 8.75e-05 | 333 | 64 | 7 | int:SRP72 | |
| Interaction | UTP14A interactions | 8.93e-05 | 230 | 64 | 6 | int:UTP14A | |
| Interaction | ARF5 interactions | 9.15e-05 | 231 | 64 | 6 | int:ARF5 | |
| Interaction | TERF2 interactions | 9.96e-05 | 340 | 64 | 7 | int:TERF2 | |
| Interaction | RIT1 interactions | METAP1 RBM25 SBNO1 NFE2L2 SMC4 DKC1 SRSF11 ANKRD20A3P EIF3C CDC5L ELL ANKRD20A1 EIF3CL | 1.09e-04 | 1230 | 64 | 13 | int:RIT1 |
| Interaction | H3C1 interactions | MYH9 TAF3 ERCC6 ARID4B BAZ1A NFE2L2 RALBP1 DKC1 EIF3C ANKRD18B LARP7 | 1.14e-04 | 901 | 64 | 11 | int:H3C1 |
| Interaction | EIF3D interactions | 1.23e-04 | 244 | 64 | 6 | int:EIF3D | |
| Interaction | SNRPA interactions | 1.38e-04 | 482 | 64 | 8 | int:SNRPA | |
| Interaction | GPR153 interactions | 1.48e-04 | 6 | 64 | 2 | int:GPR153 | |
| Interaction | H2BC4 interactions | 1.71e-04 | 259 | 64 | 6 | int:H2BC4 | |
| Interaction | DDX41 interactions | 1.84e-04 | 166 | 64 | 5 | int:DDX41 | |
| Interaction | HERC2 interactions | 1.85e-04 | 503 | 64 | 8 | int:HERC2 | |
| Interaction | SRRM4 interactions | 2.20e-04 | 37 | 64 | 3 | int:SRRM4 | |
| Interaction | LINC02910 interactions | 2.37e-04 | 95 | 64 | 4 | int:LINC02910 | |
| Interaction | HECTD1 interactions | RPF1 RBM25 ERCC6 ARID4B BAZ1A SMC4 ANKRD11 DKC1 CDC5L AP3D1 LARP7 | 2.45e-04 | 984 | 64 | 11 | int:HECTD1 |
| Interaction | TRAF3IP1 interactions | 2.47e-04 | 96 | 64 | 4 | int:TRAF3IP1 | |
| Interaction | LEO1 interactions | 2.50e-04 | 278 | 64 | 6 | int:LEO1 | |
| Interaction | CDK11A interactions | 2.68e-04 | 180 | 64 | 5 | int:CDK11A | |
| Interaction | INVS interactions | 2.78e-04 | 99 | 64 | 4 | int:INVS | |
| Interaction | EIF3F interactions | 3.50e-04 | 296 | 64 | 6 | int:EIF3F | |
| Interaction | LSM2 interactions | 3.52e-04 | 191 | 64 | 5 | int:LSM2 | |
| Interaction | KDF1 interactions | 3.60e-04 | 192 | 64 | 5 | int:KDF1 | |
| Interaction | CHD8 interactions | 3.69e-04 | 193 | 64 | 5 | int:CHD8 | |
| Interaction | SRSF4 interactions | 3.76e-04 | 300 | 64 | 6 | int:SRSF4 | |
| Interaction | HNRNPU interactions | METAP1 MYH9 ERCC6 SMC4 SRSF11 RBM8A EIF3C CDC5L ELL GOLGB1 LARP7 | 3.78e-04 | 1035 | 64 | 11 | int:HNRNPU |
| Interaction | SRSF7 interactions | 3.89e-04 | 425 | 64 | 7 | int:SRSF7 | |
| Interaction | RNPS1 interactions | 3.89e-04 | 425 | 64 | 7 | int:RNPS1 | |
| Interaction | IFI16 interactions | 4.03e-04 | 714 | 64 | 9 | int:IFI16 | |
| Interaction | SAP18 interactions | 4.10e-04 | 305 | 64 | 6 | int:SAP18 | |
| Interaction | CSNK2A2 interactions | 4.20e-04 | 718 | 64 | 9 | int:CSNK2A2 | |
| Interaction | RBBP4 interactions | 4.44e-04 | 573 | 64 | 8 | int:RBBP4 | |
| Interaction | MTA2 interactions | 4.48e-04 | 435 | 64 | 7 | int:MTA2 | |
| Interaction | SPDL1 interactions | 4.87e-04 | 315 | 64 | 6 | int:SPDL1 | |
| Interaction | PSMD1 interactions | 4.92e-04 | 442 | 64 | 7 | int:PSMD1 | |
| Interaction | H2BC9 interactions | 5.19e-04 | 446 | 64 | 7 | int:H2BC9 | |
| Interaction | PRPF40A interactions | 5.19e-04 | 446 | 64 | 7 | int:PRPF40A | |
| Interaction | ZNF330 interactions | 5.19e-04 | 446 | 64 | 7 | int:ZNF330 | |
| Interaction | CAMKV interactions | 5.41e-04 | 118 | 64 | 4 | int:CAMKV | |
| Interaction | GAGE5 interactions | 6.04e-04 | 52 | 64 | 3 | int:GAGE5 | |
| Interaction | CHD3 interactions | 6.14e-04 | 757 | 64 | 9 | int:CHD3 | |
| Interaction | RBM42 interactions | 6.31e-04 | 331 | 64 | 6 | int:RBM42 | |
| Interaction | RNF151 interactions | 6.33e-04 | 123 | 64 | 4 | int:RNF151 | |
| Interaction | RPL5 interactions | 6.41e-04 | 606 | 64 | 8 | int:RPL5 | |
| Interaction | EIF3B interactions | 6.94e-04 | 337 | 64 | 6 | int:EIF3B | |
| Interaction | STRA8 interactions | 7.57e-04 | 13 | 64 | 2 | int:STRA8 | |
| Interaction | CSNK2B interactions | 7.84e-04 | 625 | 64 | 8 | int:CSNK2B | |
| Interaction | PSMC5 interactions | 8.41e-04 | 484 | 64 | 7 | int:PSMC5 | |
| Interaction | CTR9 interactions | 8.66e-04 | 233 | 64 | 5 | int:CTR9 | |
| Interaction | CEACAM16 interactions | 8.81e-04 | 14 | 64 | 2 | int:CEACAM16 | |
| Interaction | BRD7 interactions | 8.87e-04 | 637 | 64 | 8 | int:BRD7 | |
| Interaction | ADARB1 interactions | 8.93e-04 | 489 | 64 | 7 | int:ADARB1 | |
| Interaction | POLR1G interactions | 8.93e-04 | 489 | 64 | 7 | int:POLR1G | |
| Interaction | NCL interactions | 8.94e-04 | 798 | 64 | 9 | int:NCL | |
| GeneFamily | Ankyrin repeat domain containing | ASAP2 ANKRD20A4P ANKAR ANKRD11 ANKRD20A2P ANKRD12 ANKRD20A3P ANKRD20A1 ANKRD18B | 8.51e-09 | 242 | 46 | 9 | 403 |
| GeneFamily | Septins | 4.85e-04 | 13 | 46 | 2 | 732 | |
| GeneFamily | RNA binding motif containing | 2.07e-03 | 213 | 46 | 4 | 725 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | PPIG AHI1 TUT4 ARID4B BAZ1A RALBP1 SMC4 SRSF11 EEA1 CDC5L GOLGB1 LARP7 | 4.54e-08 | 656 | 63 | 12 | M18979 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 6.80e-07 | 208 | 63 | 7 | MM581 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 4.57e-06 | 394 | 63 | 8 | MM3724 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.03e-05 | 206 | 63 | 6 | M2817 | |
| Coexpression | RB_P107_DN.V1_DN | 1.33e-05 | 126 | 63 | 5 | M2801 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP | 1.55e-05 | 130 | 63 | 5 | M6590 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP | 4.23e-05 | 265 | 63 | 6 | M19170 | |
| Coexpression | GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP | 6.27e-05 | 174 | 63 | 5 | M8925 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 6.30e-05 | 417 | 63 | 7 | M39224 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 6.63e-05 | 90 | 63 | 4 | M39250 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 7.86e-05 | 432 | 63 | 7 | M41149 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | PPIG RBM25 BAZ1A SMC4 ANKRD11 SRSF11 RBM8A EIF3C CDC5L RPS27L EIF3CL | 7.98e-05 | 1144 | 63 | 11 | MM3843 |
| Coexpression | HAHTOLA_SEZARY_SYNDROM_UP | 9.61e-05 | 99 | 63 | 4 | M14577 | |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP | 1.18e-04 | 199 | 63 | 5 | M3328 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 1.21e-04 | 200 | 63 | 5 | M9472 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 1.29e-04 | 203 | 63 | 5 | MM3795 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 1.39e-04 | 206 | 63 | 5 | M39254 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 1.46e-04 | 822 | 63 | 9 | M6782 | |
| Coexpression | MULLIGHAN_NPM1_SIGNATURE_3_UP | 1.53e-04 | 335 | 63 | 6 | M10277 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.59e-04 | 212 | 63 | 5 | M39221 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 1.84e-04 | 219 | 63 | 5 | M41199 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_MATURE_NK_T_CELL_AGEING | 1.89e-04 | 118 | 63 | 4 | MM3754 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.92e-04 | 221 | 63 | 5 | M39222 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | JAK1 PPIG MYH9 TUT4 DENND1B ARID4B USP42 SBNO1 BAZ1A ANKRD11 ELL SEPTIN6 | 1.97e-04 | 1492 | 63 | 12 | M40023 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | 2.32e-04 | 687 | 63 | 8 | M41022 | |
| Coexpression | FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL | 2.44e-04 | 365 | 63 | 6 | M41711 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 2.55e-04 | 523 | 63 | 7 | M12707 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 2.89e-04 | 534 | 63 | 7 | MM1054 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_NEGATIVE | 3.26e-04 | 136 | 63 | 4 | M40899 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN | 3.54e-04 | 139 | 63 | 4 | M9006 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | PPIG RBM25 AHI1 TUT4 DENND1B ARID4B USP42 SBNO1 BAZ1A CEP135 SMC4 DKC1 SRSF11 CDC5L LARP7 RSRC1 | 4.25e-07 | 1257 | 62 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.58e-07 | 432 | 62 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | PPIG RBM25 AHI1 TUT4 DENND1B ARID4B UNCX USP42 SBNO1 BAZ1A CEP135 SMC4 DKC1 SRSF11 CDC5L LARP7 RSRC1 | 5.88e-07 | 1459 | 62 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.40e-06 | 298 | 62 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | PPIG RBM25 AHI1 TUT4 ARID4B UNCX SBNO1 EGR1 BAZ1A CEP135 SMC4 DKC1 SLC4A4 RSRC1 RPS27L | 1.55e-05 | 1468 | 62 | 15 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.70e-05 | 186 | 62 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | PPIG TAF3 TUT4 ERCC6 ARID4B EGR1 BAZ1A NFE2L2 SMC4 SRSF11 GOLGB1 CCDC63 | 2.44e-05 | 989 | 62 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.33e-05 | 311 | 62 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | PPIG RBM25 AHI1 TUT4 ARID4B SBNO1 BAZ1A CEP135 SMC4 DKC1 SLC4A4 RSRC1 RPS27L | 4.94e-05 | 1241 | 62 | 13 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 8.85e-05 | 492 | 62 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | PPIG RBM25 AHI1 TUT4 DENND1B ARID4B MAP1A BAZ1A CEP135 SMC4 GNPTG LARP7 REV1 | 1.35e-04 | 1370 | 62 | 13 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.52e-04 | 532 | 62 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.03e-04 | 291 | 62 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | PPIG RBM25 AHI1 TUT4 DENND1B ARID4B MAP1A BAZ1A CEP135 SMC4 RSRC1 | 2.22e-04 | 1060 | 62 | 11 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.26e-04 | 564 | 62 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.59e-04 | 339 | 62 | 6 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 4.68e-04 | 629 | 62 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 4.99e-04 | 978 | 62 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | PPIG RBM25 TUT4 ARID4B EGR1 CEP135 SMC4 SRSF11 GOLGB1 CCDC63 | 5.03e-04 | 979 | 62 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | 5.62e-04 | 492 | 62 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_500 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | PPIG RBM25 TAF3 SBNO1 CCDC146 BAZ1A RALBP1 SMC4 ANKRD11 ANKRD12 GOLGB1 | 6.59e-15 | 198 | 65 | 11 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | PPIG RBM25 TAF3 SBNO1 BAZ1A RALBP1 ANKRD11 ANKRD12 EEA1 AP3D1 GOLGB1 | 6.97e-15 | 199 | 65 | 11 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | PPIG RBM25 ARID4B SBNO1 BAZ1A RALBP1 ANKRD11 ANKRD12 EEA1 GOLGB1 RPS27L | 6.97e-15 | 199 | 65 | 11 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | PPIG ARID4B SBNO1 CCDC146 BAZ1A ANKRD11 ANKRD12 EEA1 AP3D1 GOLGB1 LARP7 | 6.97e-15 | 199 | 65 | 11 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PPIG RBM25 TAF3 ARID4B EGR1 BAZ1A RALBP1 ANKRD11 ANKRD12 GOLGB1 | 1.77e-13 | 187 | 65 | 10 | 663991a8afe652e92363b64bcbd68c14d0307f0e |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | ARID4B SBNO1 CCDC146 BAZ1A RALBP1 ANKRD11 ANKRD12 EEA1 AP3D1 GOLGB1 | 3.31e-13 | 199 | 65 | 10 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-12 | 188 | 65 | 9 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.27e-11 | 197 | 65 | 9 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | PPIG SBNO1 RALBP1 ANKRD11 SEPTIN11 ANKRD12 EEA1 GOLGB1 LARP7 | 1.39e-11 | 199 | 65 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.39e-11 | 199 | 65 | 9 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.31e-09 | 138 | 65 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | S100B DENND1B ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A1 SEPTIN6 | 9.72e-09 | 184 | 65 | 7 | c6affa0b12510363258f65e46bf2d47bf4a8e75f |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | S100B DENND1B ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A1 SEPTIN6 | 9.72e-09 | 184 | 65 | 7 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 |
| ToppCell | Control-Myeloid-cDC1|World / Disease state, Lineage and Cell class | S100B DENND1B ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A1 SEPTIN6 | 1.05e-08 | 186 | 65 | 7 | 3de803dee3ef10eb85a2b47d3f93385214e5b0ff |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | S100B DENND1B ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A1 SEPTIN6 | 1.05e-08 | 186 | 65 | 7 | 962c2dada19185628ead77c32fcb07fa95114247 |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | S100B DENND1B ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A1 SEPTIN6 | 1.05e-08 | 186 | 65 | 7 | b05c394aa3573ba855abc3066739ca193883b0c3 |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | S100B DENND1B ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A1 SEPTIN6 | 1.13e-08 | 188 | 65 | 7 | 2331a2bae1383820d598e93aa86c75b101069bac |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | S100B DENND1B ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A1 SEPTIN6 | 1.26e-08 | 191 | 65 | 7 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | S100B DENND1B ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A1 SEPTIN6 | 1.30e-08 | 192 | 65 | 7 | bd3d00b094d92463b06023361a71240851a542b8 |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.67e-08 | 199 | 65 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.73e-08 | 200 | 65 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-07 | 186 | 65 | 6 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-07 | 187 | 65 | 6 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 3.31e-07 | 188 | 65 | 6 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-07 | 189 | 65 | 6 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.52e-07 | 190 | 65 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.74e-07 | 192 | 65 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Non-neuronal-Non-dividing|World / Primary Cells by Cluster | 3.98e-07 | 194 | 65 | 6 | 0add09d97192b34bd506209ab5f1a77182f498fc | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 4.22e-07 | 196 | 65 | 6 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 4.35e-07 | 197 | 65 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.35e-07 | 197 | 65 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon|organoid_Velasco_nature / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-07 | 198 | 65 | 6 | a6f65bb0845d8f64f5c7edb00cee3ca5adb1a373 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.48e-07 | 198 | 65 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.48e-07 | 198 | 65 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 4.48e-07 | 198 | 65 | 6 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.62e-07 | 199 | 65 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.75e-07 | 200 | 65 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.61e-06 | 135 | 65 | 5 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.99e-06 | 170 | 65 | 5 | 81341bf4fe090af70b2091b6b2579ed08d76e22d | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 5.29e-06 | 172 | 65 | 5 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.75e-06 | 175 | 65 | 5 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.96e-06 | 182 | 65 | 5 | 6f5228ac47f9ab46d165740cf2655b5ba217acbe | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 7.53e-06 | 185 | 65 | 5 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.93e-06 | 187 | 65 | 5 | 1e8651e6c547384ace5a66b96c6b24a7f390a7ee | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.14e-06 | 188 | 65 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.14e-06 | 188 | 65 | 5 | d5ce3ffe783c322b4765b790e861727e46bc34b3 | |
| ToppCell | Non-neuronal-Non-dividing-OPC|World / Primary Cells by Cluster | 8.35e-06 | 189 | 65 | 5 | 13848a031ab896b4b24c8319e4745b9b17ff9cfd | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC|World / Primary Cells by Cluster | 8.35e-06 | 189 | 65 | 5 | ddf5be73912570c32c50f4ac2902da9b590526f8 | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC-30|World / Primary Cells by Cluster | 8.35e-06 | 189 | 65 | 5 | 313d165fad541ec6e8dd524b88856e2c93eeb681 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.57e-06 | 190 | 65 | 5 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.79e-06 | 191 | 65 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.79e-06 | 191 | 65 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.79e-06 | 191 | 65 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.01e-06 | 192 | 65 | 5 | 430ef714bf2544d32f3fd96a55af010f79aa9be0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-06 | 193 | 65 | 5 | d994b2f2707877288f88cab7cd6002ef91962c50 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 9.24e-06 | 193 | 65 | 5 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.24e-06 | 193 | 65 | 5 | 7386fadc13a437f3b0c99b5d116cd3c5f893529c | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia|World / Primary Cells by Cluster | 9.48e-06 | 194 | 65 | 5 | 1445b7611c2b1ab9b320f330d17d70117892cc28 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 9.48e-06 | 194 | 65 | 5 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.72e-06 | 195 | 65 | 5 | 32ec72103faccc9e37c0ecedff1998e7df6a19f6 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 9.96e-06 | 196 | 65 | 5 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.96e-06 | 196 | 65 | 5 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 1.05e-05 | 198 | 65 | 5 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.07e-05 | 199 | 65 | 5 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.07e-05 | 199 | 65 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.54e-05 | 142 | 65 | 4 | 1eecbec805a873fa3539df0574670cf73c18c7b1 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.68e-05 | 149 | 65 | 4 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD1c+_DCs|metastatic_Brain / Location, Cell class and cell subclass | 8.60e-05 | 159 | 65 | 4 | 35a63ca521635389a1edc7c81157793b8ad24d38 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 170 | 65 | 4 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 171 | 65 | 4 | 1018d7bd378ce20bee56a77d5851b3538c55098c | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 171 | 65 | 4 | 173bb5318fdbaef6e695b6f9e3e0ff4a5432a1a4 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 171 | 65 | 4 | 6bda333bb751d7835a04f21ac959eea79f2516aa | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 173 | 65 | 4 | d13ae4046a25ee0fb492ddedf44583a879a432e9 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.22e-04 | 174 | 65 | 4 | 5ec8a48a390379d6c422120dce46437a77da67cc | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 175 | 65 | 4 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.27e-04 | 176 | 65 | 4 | 195393b38f1335f2cb96125616d75c164a6026c2 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Primitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 176 | 65 | 4 | 664a7d15563428d0ae156d97aa88415fd0a0506a | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD141+_DCs|metastatic_Brain / Location, Cell class and cell subclass | 1.27e-04 | 176 | 65 | 4 | b9ba7026dee2272c0b483dc0cfa39f74b75f1634 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 177 | 65 | 4 | e73e2b6a72630bb56ac2af1cdeedc8f0f828f390 | |
| ToppCell | C_00|World / shred on cell type and cluster | 1.36e-04 | 179 | 65 | 4 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 182 | 65 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 182 | 65 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 182 | 65 | 4 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 183 | 65 | 4 | d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.48e-04 | 183 | 65 | 4 | 523896bd1a93bdda81a009768baa3a1bdbd108b8 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.48e-04 | 183 | 65 | 4 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-04 | 184 | 65 | 4 | a6f8b42982ec0cf44b950a2cd9715d068eec4ecb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 184 | 65 | 4 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.51e-04 | 184 | 65 | 4 | 667846c422cfa27e949a24844a305df859cb6760 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-04 | 184 | 65 | 4 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 185 | 65 | 4 | 1f37191eeddaf95e1ad1a206fee86525a2e94e51 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 185 | 65 | 4 | 70d3f804b43a8843c5af53aefe677fdfc8bb61ff | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-conventional_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 185 | 65 | 4 | 209c7d769dd01c349f0a6d147ac9d6225a85160f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 186 | 65 | 4 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 186 | 65 | 4 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 187 | 65 | 4 | 3748203b62abf51b74dfcfc4f18b3ba831b63a96 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 187 | 65 | 4 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.60e-04 | 187 | 65 | 4 | db771e952f71a12886c2dbc77c6cd07054ef809a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 188 | 65 | 4 | c39083b8020ae507246959abbb299d78bcd14042 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 6.07e-07 | 178 | 63 | 7 | 3998_DN | |
| Drug | torcetrapib | 4.51e-06 | 342 | 63 | 8 | ctd:C483909 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 9.54e-06 | 177 | 63 | 6 | 985_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.02e-05 | 179 | 63 | 6 | 4585_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.30e-05 | 187 | 63 | 6 | 4302_DN | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; HL60; HG-U133A | 1.80e-05 | 198 | 63 | 6 | 1579_DN | |
| Disease | Cataract | 6.21e-05 | 37 | 61 | 3 | C0086543 | |
| Disease | twisted gastrulation protein homolog 1 measurement | 1.17e-04 | 8 | 61 | 2 | EFO_0803205 | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 1.87e-04 | 10 | 61 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | pulmonary emphysema (is_marker_for) | 3.76e-04 | 14 | 61 | 2 | DOID:9675 (is_marker_for) | |
| Disease | chin morphology measurement | 4.17e-04 | 70 | 61 | 3 | EFO_0007842 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 4.34e-04 | 15 | 61 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | blood phosphate measurement | 4.69e-04 | 174 | 61 | 4 | EFO_0010972 | |
| Disease | IGF-1 measurement | 5.10e-04 | 488 | 61 | 6 | EFO_0004627 | |
| Disease | Pseudoaphakia | 1.13e-03 | 24 | 61 | 2 | C0524524 | |
| Disease | Lens Opacities | 1.13e-03 | 24 | 61 | 2 | C1510497 | |
| Disease | ocular sarcoidosis | 1.80e-03 | 116 | 61 | 3 | EFO_0010723 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ILEHKKKILKKEKSD | 251 | Q5TYW2 | |
| KHRKKIKNKLDKEKD | 636 | Q4LE39 | |
| KKDKQHLKRKKESDL | 261 | Q99459 | |
| KSKKHKDKERAAEDK | 451 | P55199 | |
| SAINILKEKKKREKH | 1451 | Q6UB99 | |
| HDDKLSSEKRKKKKE | 226 | Q8N157 | |
| ILEHKKKILKKEKSD | 251 | Q4UJ75 | |
| IHKEKQVRKKEHKLK | 226 | Q8N4X5 | |
| KKLKKRKEGAKAEHN | 286 | A2A2Z9 | |
| EGKTLKKHKLKHKER | 646 | Q6UB98 | |
| FEKEKKIKHEHKSEK | 841 | Q6UB98 | |
| LSKKEERLKKHIKKL | 321 | Q03468 | |
| KLKREKADALEAKKK | 326 | Q9NRL2 | |
| LKKAKESKKHEKLEK | 531 | Q76M96 | |
| KHRKEKEERTKGKKK | 876 | O14617 | |
| HKEEKHKEKKSKDLT | 141 | Q15311 | |
| SHPRKKKKEKKEDIF | 231 | P49756 | |
| GDESIHKLKEKAKKR | 21 | Q9Y5S9 | |
| KEKNKLKRKKLENKH | 336 | P23458 | |
| LKRKKLENKHKKDEE | 341 | P23458 | |
| LKKEKKHDKYRVEKL | 61 | Q08AF8 | |
| ILEHKKKILKKEKSD | 251 | Q5SQ80 | |
| KKIIQKHFEKKKDIR | 296 | Q7Z5J8 | |
| LSKKEERLKKHIKKL | 321 | P0DP91 | |
| LHKKAKDEKAKREVS | 51 | P53582 | |
| EKRKLIKDKVGKKHL | 391 | P78559 | |
| GKKHLKEKISKLEEK | 401 | P78559 | |
| KITKIEKEKKEHAKL | 156 | O43150 | |
| KIHLRQKDKKADKSV | 416 | P18146 | |
| KEKGENDKSLHLLKK | 541 | Q16236 | |
| ELKKDKKHSKEKKGS | 491 | P35663 | |
| DLKDSSLLKTKRKHK | 346 | Q4G0J3 | |
| EEEKSKSLAKLKNKH | 1011 | P35579 | |
| SATEEKSKKRKKKHR | 221 | Q13427 | |
| HKLKLLEKESKAKNE | 126 | Q66GS9 | |
| EKKREDKAKKKHDRK | 271 | Q99613 | |
| DKAKKKHDRKSKRLD | 276 | Q99613 | |
| KKSLEKEKEASHQLK | 916 | Q15075 | |
| RKAHKELSKEIKRLK | 246 | Q9UJJ9 | |
| EKKREDKAKKKHDRK | 271 | B5ME19 | |
| DKAKKKHDRKSKRLD | 276 | B5ME19 | |
| ILEHKKKILKKEKSD | 251 | Q5VUR7 | |
| LKKEKKHDKYRVEKL | 61 | Q0D2H9 | |
| KREEALKAKKHVKKN | 281 | Q8NA47 | |
| KRARHKLKKKEKEKA | 496 | Q96PV7 | |
| KDEKRKEKWKHARVK | 101 | Q9UQ88 | |
| KDVSHKAQKKRKKDR | 431 | Q8N6R0 | |
| KKHKKKKERKSLPEE | 11 | O60832 | |
| KLGLKEVKSKLKHKE | 456 | Q6P3S1 | |
| PWLIRKDHKKNKEKK | 776 | A3KN83 | |
| DKKKKYETKVHRKTL | 186 | Q8N9I0 | |
| DGLVRKEKEKHKDKK | 606 | Q5VWG9 | |
| KRTHQEEKKKVEDKK | 371 | Q9NVA2 | |
| SLEEEKKKHKKKRLV | 11 | Q71UM5 | |
| HEKKGREKKRKKSEK | 41 | A0A1B0GVY4 | |
| REGDKHKLKKSELKE | 21 | P04271 | |
| LKKLHQDEKKKLEDK | 371 | Q14141 | |
| HKKKKRLAKNKSRDN | 396 | Q86UX6 | |
| KAKDLEIRIHKKKKC | 491 | Q8IYE0 | |
| AKKKLKKEREALGDK | 81 | Q9H9Y2 | |
| SDADLHRHKKKKKKK | 1226 | Q9H9J4 | |
| KKKKKKRHSRKSEDF | 1236 | Q9H9J4 | |
| PRRHKKEKKKDKDKE | 371 | Q05519 | |
| LLHLKAAVKEKKRNK | 1061 | Q9UBZ9 | |
| KRKVDKKKKNLHRAS | 21 | Q5MJ08 | |
| KKHKQDRGEKKLLKC | 216 | Q6ECI4 | |
| REKLKHATSKAKKLE | 401 | Q9NTJ3 | |
| AKEKELVKKQLKKHL | 146 | Q96EU6 | |
| KREKEKDKGKDKELH | 146 | Q96IZ7 | |
| KRKTGHKEKKEKERI | 46 | Q9Y6R1 | |
| KHIKEKRHKKNILEK | 321 | Q5TAX3 | |
| EKKKRKHEKKLLKSQ | 201 | A6NJT0 | |
| RKAADNKIKKLKLHA | 86 | Q14789 |